|
US4395423A
(en)
|
1978-10-10 |
1983-07-26 |
Sterling Drug Inc. |
Polycyclic cyanoketones
|
|
US5064823A
(en)
|
1988-08-24 |
1991-11-12 |
Research Triangle Institute |
Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
|
|
DE19817262A1
(de)
|
1998-04-18 |
1999-10-21 |
Bayer Ag |
Neue 2-heterocyclisch substituierte Dihydropyrimidine
|
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
|
US6369101B1
(en)
|
1999-02-26 |
2002-04-09 |
Regents Of The University Of Minnesota |
Therapeutic method to treat herpes virus infection
|
|
DE60043400D1
(de)
|
1999-05-14 |
2010-01-07 |
Nereus Pharmaceuticals Inc |
Interleukin-1 und Tumornekrosefaktor-alpha Modulatoren,Synthese dieser Modulatoren und Methoden zur Anwendung dieser Modulatoren
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
WO2002003996A1
(en)
|
2000-07-12 |
2002-01-17 |
RAJKUMAR, Sujatha |
Use of dammarane-type tritepenoid saporins
|
|
AU2001294953A1
(en)
|
2000-09-29 |
2002-04-08 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
|
US6951847B2
(en)
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
|
WO2002047611A2
(en)
|
2000-11-28 |
2002-06-20 |
Board Of Regents, The University Of Texas System |
Cddo-compounds and combination therapies thereof
|
|
US7176237B2
(en)
|
2002-01-15 |
2007-02-13 |
The Trustees Of Dartmouth College |
Tricyclic-bis-enone derivatives and methods of use thereof
|
|
CA2473799A1
(en)
|
2002-01-18 |
2003-07-31 |
Regents Of The University Of Minnesota |
Triterpene quaternary salts as biologically active surfactants
|
|
JP2006515859A
(ja)
|
2002-05-13 |
2006-06-08 |
トラスティーズ オブ ダートマス カレッジ |
阻害剤およびその使用法
|
|
US20050208151A1
(en)
|
2003-10-30 |
2005-09-22 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with FLIP antagonists
|
|
US8288439B2
(en)
|
2003-11-04 |
2012-10-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the inhibition of HIV-1 replication
|
|
US20060258752A1
(en)
|
2004-02-12 |
2006-11-16 |
Vander Jagt David L |
Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
|
|
JP5087400B2
(ja)
|
2004-09-07 |
2012-12-05 |
パシフィック アロー リミテッド |
アンゲロイル基を有する抗腫瘍化合物
|
|
AU2006265113A1
(en)
|
2005-07-01 |
2007-01-11 |
The Johns Hopkins University |
Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
|
|
US20070232577A1
(en)
|
2006-03-23 |
2007-10-04 |
Advanced Life Sciences, Inc. |
Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
|
|
US20070249561A1
(en)
|
2006-04-25 |
2007-10-25 |
Taylor Bradley K |
Pharmacological method for treatment of neuropathic pain
|
|
WO2008000068A1
(en)
|
2006-06-27 |
2008-01-03 |
Wellington Laboratories Inc. |
Method for preparing 2-iodo triterpenoid compounds
|
|
WO2008016095A1
(en)
|
2006-08-02 |
2008-02-07 |
Santen Pharmaceutical Co., Ltd. |
PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
|
|
EP2094651A1
(en)
|
2006-11-17 |
2009-09-02 |
Trustees Of Dartmouth College |
Synthesis and biological activities of new tricyclic-bis-enones (tbes)
|
|
US8299046B2
(en)
|
2006-11-17 |
2012-10-30 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
|
EP2680010A1
(en)
|
2007-02-08 |
2014-01-01 |
Biogen Idec MA Inc. |
Nrf2 screening assays and related methods and compositions
|
|
WO2008111497A1
(ja)
|
2007-03-08 |
2008-09-18 |
Santen Pharmaceutical Co., Ltd. |
トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
|
|
WO2008136838A1
(en)
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
US8088824B2
(en)
|
2007-08-15 |
2012-01-03 |
Reata Pharmaceuticals Inc. |
Forms of CDDO methyl ester
|
|
WO2009023845A2
(en)
|
2007-08-15 |
2009-02-19 |
The Board Of Regents Of The University Of Texas System |
Combination therapy with synthetic triterpenoids and gemcitabine
|
|
WO2009058849A1
(en)
|
2007-10-29 |
2009-05-07 |
University Of Rochester |
Use of electrophilic compounds for inducing platelet production or maintaining platelet function
|
|
BRPI0907423A2
(pt)
|
2008-01-11 |
2020-10-27 |
Reata Pharmaceuticals, Inc. |
composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto
|
|
KR101713140B1
(ko)
|
2008-04-18 |
2017-03-08 |
리타 파마슈티컬스 잉크. |
Ｃ-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체
|
|
MX2010011439A
(es)
|
2008-04-18 |
2011-01-25 |
Reata Pharmaceuticals Inc |
Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17.
|
|
JP5529851B2
(ja)
*
|
2008-04-18 |
2014-06-25 |
リアタ ファーマシューティカルズ インコーポレイテッド |
抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
|
|
US8071632B2
(en)
|
2008-04-18 |
2011-12-06 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
|
WO2009146218A2
(en)
|
2008-04-18 |
2009-12-03 |
Reata Pharmaceuticals, Inc. |
Compounds including an anti-inflammatory pharmacore and methods of use
|
|
EP2309860B1
(en)
|
2008-07-22 |
2014-01-08 |
Trustees of Dartmouth College |
Monocyclic cyanoenones and methods of use thereof
|
|
WO2010053817A1
(en)
|
2008-11-04 |
2010-05-14 |
Trustees Of Dartmouth College |
Betulinic acid derivatives and methods of use thereof
|
|
SI2395979T1
(sl)
|
2009-02-13 |
2017-12-29 |
Reata Pharmaceuticals, Inc. |
Peroralni farmacevtski sestavki, ki vsebujejo amorfni CDDO-Me, z zapoznelim sproščanjem
|
|
DK2558105T3
(da)
|
2010-04-12 |
2020-01-27 |
Reata Pharmaceuticals Inc |
Bardoxolonmethyl til behandling af fedme
|
|
US8618125B2
(en)
|
2011-01-14 |
2013-12-31 |
Heptiva LLC |
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
|
|
US8846647B2
(en)
|
2011-01-31 |
2014-09-30 |
Bristol-Myers Squibb Company |
C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
|
|
MX348862B
(es)
|
2011-03-11 |
2017-07-03 |
Reata Pharmaceuticals Inc |
Derivados c4-monometil triterpenoides y sus metodos de uso.
|
|
TWI623548B
(zh)
|
2012-04-27 |
2018-05-11 |
瑞塔醫藥有限責任公司 |
齊墩果酸（ｂａｒｄｏｘｏｌｏｎｅ ｍｅｔｈｙｌ）之２，２-二氟基丙醯胺衍生物、多晶型及其使用方法
|
|
US8921419B2
(en)
|
2012-05-08 |
2014-12-30 |
Trustees Of Dartmouth College |
Triterpenoids and compositions containing the same
|
|
WO2013169740A2
(en)
|
2012-05-08 |
2013-11-14 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
|
|
WO2013188818A1
(en)
|
2012-06-15 |
2013-12-19 |
Reata Pharmaceuticals, Inc. |
A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
|
|
CN103665087A
(zh)
|
2012-09-03 |
2014-03-26 |
上海源力生物技术有限公司 |
一种萜类化合物及其在医药上的应用
|
|
SMT201700501T1
(it)
*
|
2012-09-10 |
2017-11-15 |
Reata Pharmaceuticals Inc |
Derivati c17-eteroarilici dell'acido oleanolico e metodi d'uso degli stessi
|
|
JP6243428B2
(ja)
|
2012-09-10 |
2017-12-06 |
リアタ ファーマシューティカルズ インコーポレイテッド |
オレアノール酸のｃ１７−アルカンジイルおよびアルケンジイル誘導体ならびにその使用方法
|
|
WO2014040073A1
(en)
|
2012-09-10 |
2014-03-13 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
|
JP2015527407A
(ja)
|
2012-09-10 |
2015-09-17 |
アッヴィ・インコーポレイテッド |
グリチルレチン酸誘導体およびその使用方法
|
|
US9512094B2
(en)
|
2012-09-10 |
2016-12-06 |
Reata Pharmaceuticals, Inc. |
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
|
|
AR096046A1
(es)
|
2013-04-24 |
2015-12-02 |
Abbvie Inc |
Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso
|
|
EP4736949A2
(en)
|
2013-08-23 |
2026-05-06 |
Reata Pharmaceuticals Holdings, LLC |
Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
|
|
WO2016033132A1
(en)
|
2014-08-26 |
2016-03-03 |
Trustees Of Dartmouth College |
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
|
|
JP7074674B2
(ja)
*
|
2015-09-23 |
2022-05-24 |
リアタ ファーマシューティカルズ インコーポレイテッド |
Ｉｌ－１７の阻害及び他の使用のためのｃ４修飾オレアノール酸誘導体
|
|
CN110198718B
(zh)
|
2016-11-08 |
2023-01-10 |
里亚塔医药控股有限责任公司 |
使用甲基巴多索隆或其类似物治疗阿尔波特综合征的方法
|
|
EP3999522B1
(en)
|
2019-07-19 |
2025-09-03 |
Reata Pharmaceuticals, Inc. |
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
|